Trials / Completed
CompletedNCT06969664
A Trial of SHR7280 in Healthy Subjects
A Phase I Clinical Study to Evaluate Effect of High-Fat Diet on Pharmacokinetics of a Single Oral Dose of SHR7280 Tablets and to Assess the Effect of SHR7280 on QT Interval in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR7280 Tablet | Oral SHR7280 tablet. |
| DRUG | SHR7280 Placebo Tablet | Oral SHR7280 placebo tablet. |
Timeline
- Start date
- 2025-05-19
- Primary completion
- 2025-07-05
- Completion
- 2025-07-05
- First posted
- 2025-05-14
- Last updated
- 2025-08-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06969664. Inclusion in this directory is not an endorsement.